BLIS TechnologiesNZSE:BLT +6.25% Median PS Value is NZ$0.04 as of Jun. 29, 2026, which is 100% below its 10-year median of 0.46. The stock has 4 warning signs investors should review. Among 277 Biotechnology companies, BLIS Technologies ranks better than 69.68% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for BLIS Technologies's Median PS Value or its related term are showing as below:
NZSE:BLT'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.28 Med: 0.46 Max: 1.1
Current: 0.43
During the past 13 years, the highest Price to Median PS Value of BLIS Technologies was 1.10. The lowest was 0.28. And the median was 0.46.
NZSE:BLT's Price-to-Median-PS-Value is ranked better than 69.68% of 277
companies
in the Biotechnology industry
Industry Median: 0.62
vs NZSE:BLT: 0.43
BLIS Technologies (NZSE:BLT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
BLIS Technologies's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.017
/
0.04
=
0.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLIS Technologies Median PS Value Related Terms
BLIS Technologies Median PS Value Historical Data
* Premium members only.
The historical data trend for BLIS Technologies's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:BLT vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, BLIS Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BLIS Technologies Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BLIS Technologies's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where BLIS Technologies's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.6364.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BLIS Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.011.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLIS Technologies (NZSE:BLT) has a Median PS Value of NZ$0.04 as of Jun. 29, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on BLIS Technologies and its competitors. This is 91% below median its historical median of 0.46. Over the past decade, BLIS Technologies' Median PS Value has ranged from 0.28 to 1.10. According to the industry distribution chart, BLIS Technologies ranks #84 out of 277 companies in the Biotechnology industry, placing it in the top 30.3%.
Is BLIS Technologies' Median PS Value too high?
BLIS Technologies' current Median PS Value of NZ$0.04 is 91% below median its 10-year median of 0.46. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 1.10. Based on the distribution chart, BLIS Technologies ranks #84 out of 277 companies in the Biotechnology industry, which is above the industry midpoint.
How does BLIS Technologies' Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BLIS Technologies ranks #84 out of 277 companies for Median PS Value. This puts BLIS Technologies in the upper half of its industry. The industry median Median PS Value is 0.62. Historically, BLIS Technologies' own Median PS Value has ranged from 0.28 to 1.10 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.62, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on BLIS Technologies and its competitors. For the Biotechnology industry, the median Median PS Value is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BLIS Technologies's current Median PS Value is NZ$0.04, which is 91% below median its own 10-year median of 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLIS Technologies stock overvalued right now?
Based on GuruFocus' analysis, BLIS Technologies (NZSE:BLT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$0.02, compared to a current price of NZ$0.02 — trading 15% below its estimated fair value. The current Median PS Value is NZ$0.04, which is 91% below median its 10-year median of 0.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For BLIS Technologies (NZSE:BLT), the current Median PS Value is NZ$0.04 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:BLT has been successfully added to your 